GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | 10/30/2026 5:13:08 PM | View | Financials | Earnings | SEC | 3Q 2026 | Export Earnings Model | ||||
| Rapport Therapeutics, Inc. (RAPP) | 8/5/2026 7:43:19 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $458,982,000 | EPS -$1.19 | ||
| Rapport Therapeutics, Inc. (RAPP) | 8/5/2026 7:18:03 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $0 | Assets $458,982,000 | EPS -$1.19 | Export Earnings Model | |
| Rapport Therapeutics, Inc. (RAPP) | 5/7/2026 7:44:00 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $20,000,000 | Assets $497,597,000 | EPS -$0.42 | |
| Rapport Therapeutics, Inc. (RAPP) | 5/7/2026 7:16:44 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $20,000,000 | Assets $497,597,000 | EPS -$0.42 | Export Earnings Model | |
| Rapport Therapeutics, Inc. (RAPP) | 4/23/2026 7:21:06 AM | View | Proxy | SEC | Y 2025 | ||||||
| Rapport Therapeutics, Inc. (RAPP) | 3/10/2026 7:32:16 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $512,431,000 | EPS -$2.86 | ||
| Rapport Therapeutics, Inc. (RAPP) | 3/10/2026 7:12:25 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $512,431,000 | EPS -$0.71 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 11/6/2025 7:46:54 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $535,323,000 | EPS -$0.71 | ||
| Rapport Therapeutics, Inc. (RAPP) | 11/6/2025 7:16:43 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $535,323,000 | EPS -$0.71 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 8/7/2025 7:46:55 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $285,495,000 | EPS -$0.75 | ||
| Rapport Therapeutics, Inc. (RAPP) | 8/7/2025 7:16:39 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $285,495,000 | EPS -$0.75 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 5/8/2025 7:45:14 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $302,053,000 | EPS -$0.68 | ||
| Rapport Therapeutics, Inc. (RAPP) | 5/8/2025 7:16:22 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $302,053,000 | EPS -$0.68 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 4/24/2025 6:10:39 AM | View | Proxy | SEC | Y 2024 | ||||||
| Rapport Therapeutics, Inc. (RAPP) | 3/11/2025 7:45:26 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $314,933,000 | EPS -$3.78 | ||
| Rapport Therapeutics, Inc. (RAPP) | 3/11/2025 7:15:31 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $314,933,000 | EPS -$0.12 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 11/7/2024 7:41:10 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $331,144,000 | EPS -$0.50 | ||
| Rapport Therapeutics, Inc. (RAPP) | 11/7/2024 7:16:53 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $331,144,000 | EPS -$0.50 | Export Earnings Model | ||
| Rapport Therapeutics, Inc. (RAPP) | 8/8/2024 7:58:43 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $346,098,000 | EPS -$1.70 | ||
| Rapport Therapeutics, Inc. (RAPP) | 8/8/2024 7:21:43 AM | View | Earnings | SEC | 2Q 2024 | Assets $346,098,000 | EPS -$1.70 |